Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
Hosted by TABS Inc., Laura Devine Immigration, Frazier & Deeter and Seven Legal, this event is your chance to learn from experts about expanding your business to the US and how to secure funding for your venture. Join us for an informative panel discussion and workshop that will help you navigate the complexities of the American market. Don’t miss out on this opportunity to gain valuable insights and network with other founders looking to expand to the US market.
Who should attend?
In this panel webinar, we will discuss how artificial intelligence is advancing the prediction of molecular properties such as absorption, distribution, metabolism, and excretion (ADME). You will learn how Cresset’s AI-powered solution leverages machine learning techniques to efficiently identify promising drug candidates, reduce experimental workload, and accelerate candidate selection. We will cover practical strategies on how to use these AI models in your organization and how they can make drug discovery projects run more smoothly.
SoluLyse™ from Amsbio is a bacterial protein extraction reagent that provides a highly efficient yet gentle method for extracting soluble proteins from bacterial cells.
Based upon a proprietary non-ionic detergent formulation, with the SoluLyse™ reagent there is no need for time-consuming and cumbersome secondary treatment methods such as sonication or freeze thaw. The unique, mild SoluLyse™ formulation allows perforation of bacterial cell walls without denaturing proteins.
Based at Alderley Park, Medicines Discovery Catapult is a national Life Sciences service dedicated to turning drug discovery into commercial breakthroughs. We accelerate the development of science, and where there are areas of unmet patient need, we stimulate innovation.
About the company: TTP is an employee-owned technology and product development consultancy, with a 40-year track record of helping ambitious clients solve complex challenges and bring innovative, commercially successful solutions to market.
We invent, design, and manufacture impactful products and technologies across a wide range of industries – including healthcare, life science, energy, and communications – and at the intersection of engineering, physical science, and biology.
|
Never losing sight of our purpose
At Mestag we truly believe in our values and live by them every day. We’re ambitious about our science and its potential to deliver meaningful therapeutics to the patients that need them most. We believe in a culture of diversity, equality and investing in people to ensure our talented and passionate team members can fulfil their full potential.
Ellipses Pharma is a global drug development company headquartered in London, focused on accelerating the development of cancer treatments through an innovative drug development model that combines unbiased vetting to de-risk initial asset selection, the expertise of a Scientific Affairs Group, which comprises more than 300 leading oncologists and an uninterrupted funding flow to minimise the time it takes to advance lead products through clinical trials and reach patients.
Join us for two exciting days that will showcase an exceptional line-up of academic and industry speakers exploring breakthrough stem cell technologies transforming drug discovery and therapeutic development.
Co-hosted by the Babraham Institute and Newcastle University, the Frontiers in Stem Cell Innovation Conference will feature key talks and panel discussion sessions focused on stem cell technologies, disease modelling, and translational research.